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Nutritional management after total laryngectomy  
Background information
The patient, a 55-year-old male, was admitted to hospital on 
28 September 2010 with a known diagnosis of cancer of the larynx. 
The patient, who underwent a total laryngectomy on 13 October, had 
a tracheostomy inserted previously. Prior to the surgery the patient 
was consuming a soft diet and oral supplementation drinks. He had 
no previous history of any other illnesses. 
Course of illness
On the second day post-surgery, the patient was discharged from 
the intensive care unit and transferred back to the ear, nose and 
throat ward. A gastrografin swallow to evaluate his swallowing 
ability was booked for 19 October and radiotherapy treatment was 
planned to begin on 9 November. The first gastrografin swallow was 
unsuccessful. On the 13th day post-surgery (26 October), the patient 
was started on an oral liquid diet. However, he was still only able to 
swallow small amounts of fluid, most of which came back through his 
nose. A second gastrografin swallow was booked for 10 November. 
The patient’s ability to swallow had improved but partial obstruction 
of the oesophagus was still suspected. The patient underwent 
an oesophageal dilatation and had a percutaneous endoscopic 
gastrostomy (PEG) tube inserted for feeding on 17 November, 
34 days after admission. He was discharged from hospital on 
19 November. For the patient’s antropometric details, see Table I.
Biochemistry
Prior to admission, on 14 September, the patient’s serum 
concentrations for sodium, urea and creatinine were 114 mmol/l, 
1.2 mmol/l and 25 mmol/l, respectively. These low levels may indicate 
chronic malnutrition. By 15 November, sodium, urea and creatinine 
had normalised to 140 mmol/l, 5 mmo/l and 58 mmol/l, respectively, 
after treatment and nutritional support. The only available value for 
albumin was 28 g/l on 9 October. 
Nutritional management 
The patient was referred to the dietitian on 14 October for nutritional 
management. The nutritional calculations were done on an ideal 
body weight of 60 kg (body mass index, BMI, of 20 kg/m2), as the 
patient’s BMI was classified as being grade 1 undernutrition. 
The surgeons requested supplementary total parenteral nutrition 
(TPN), and thus the European Society for Clinical Nutrition and 
Metabolism (ESPEN) guidelines for parenteral nutrition were used,1 
as follows:
• Energy: 1 500-1 800 kCal/day at 25-30 kCal/kg. 
• Protein: 61-76 g/day at 1.2-1.5g/kg (using the pre-surgery 
actual body weight of 51.2 kg).
The patient received supplementary TPN between 14 October and 
9 November. During this period, initiation of an oral liquid diet was 
attempted, but the patient was unable to swallow, because of an 
oesophageal obstruction. By 10 November, he was able to tolerate 
small amounts of liquid and soft foods.The patient had a PEG tube 
inserted on 17 November, as he was expected to have difficulty 
maintaining an adequate oral intake in the future. He was encouraged 
to consume as much food per mouth as possible, and the deficit in 
reaching his energy requirements was provided via supplementary 
PEG feedings during the night.
Discussion 
Patients undergoing major surgery for head and neck cancers 
are often undernourished before surgery and are therefore at 
an increased risk for postoperative complications.1 Nutritional 
support is thus vitally important. These patients will not be able to 
eat orally post-surgery for a variety of reasons, such as swelling 
and obstruction. Enteral nutrition, or a combination of enteral and 
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Table I: Anthropometric data
Weight Prior to surgery 51.2 kg




Body mass index Before surgery 17.2 kg/m2
At discharge 16.1 kg/m2
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supplementary parenteral nutrition, is the recommended first choice 
intervention.2,3 
The presence of an oesophageal obstruction could lead to dysphagia, 
resulting in decreased food intake and subsequent weight loss. 
Oesophageal stents or dilatations are used to improve dysphagia. 
Recently, self-expanding stents have become the most common 
method for the endoscopic treatment of oesophageal cancer. These 
new stents can provide almost immediate dysphagia relief.4
Immediately following placement of the stent, the patient should 
consume a liquid diet. Within 24 hours, the patient should be able 
to progress to a semi-solid diet. In the long term, major dietary 
modifications are not necessary for patients with self-expanding 
stents. Obstruction of the stent with a food bolus can occur. To 
prevent this complication, patients should chew their food properly 
and eat smaller food portions. It is also advised to avoid large leafy 
vegetables, and meats should be finely chopped and eaten with gravy 
or sauces. Some patients will require oral nutrition supplements to 
help them achieve a high-energy, low-volume diet. 4
Placement of a stent can only alleviate dysphagia. It does not 
eliminate anorexia or the metabolic derangements associated 
with cancer. However, dysphagia, rather than the metabolic effects 
of the tumour, is the primary contributor to malnutrition for many 
oesophageal cancer patients. Stent placement will therefore help 
patients achieve adequate oral intake and improve their nutritional 
status, leading to improved quality of life and better response to 
treatment.4
Cancer treatments such as surgery and radiotherapy are known 
to have a negative impact on a patient’s nutritional and functional 
status. Side-effects of radiotherapy can lead to a patient not being 
able to maintain an adequate oral intake. The placement of a PEG is 
an effective and easy way to supplement oral intake and ensure that 
the patient meets the nutritional requirements. PEG feeding reduces 
the length of stay in hospital and thus hospital costs and improves 
response to treatment and prognosis. It is also associated with lower 
rates of morbidity and mortality.5,6 
The negative effects of the malignancy can be expected in most 
patients before treatment has even begun. It could thus be more 
beneficial in certain patients to place a prophylactic PEG.6,7 It has 
been shown that early and appropriate supplementary enteral 
nutrition via PEG is more effective than oral nutrition alone in patients 
undergoing chemotherapy or radiotherapy treatment.7 Many reviews 
have reported that head and neck cancer patients, who had had 
a PEG inserted late during their treatment course in response to 
significant weight loss, suffered greater morbidity than those who 
received it prophylactically.7 However, the use of PEG feeding, as 
is the case with any means of artificial nutrition, usually leads to 
a decrease in the patient’s quality of life. Early insertion of the PEG 
(within one month of beginning treatment) and shorter PEG duration 
have been shown to be associated with an improved quality of life 
in patients.8
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